11-5225609-T-C
Variant summary
The NM_000518.5(HBB):c.433A>G (p.Lys145Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene HBB is a known oncogene (CancerMine: 4 oncogene, 1 driver citations). The gene HBB is a cancer driver gene (CancerMine: 4 oncogene, 1 driver citations). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (no review stars). A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.K145N: Pathogenic (ClinVar VariationId 15096, 1 star) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.K145?: other (ClinVar VariationId 15604, 0 stars); p.K145*: Uncertain_significance (ClinVar VariationId 478887, 1 star); p.K145= (synonymous): Likely_benign (ClinVar VariationId 1104204, 1 star); p.K145M: other (ClinVar VariationId 15576, 0 stars); p.K145N: not_provided (ClinVar VariationId 156328) This exact variant is curated in the UniProt human variants database as Uncertain Significance.
Frequency
Consequence
NM_000518.5 missense
Scores
Clinical Significance
Conservation
Publications
- dominant beta-thalassemiaInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia, Natera
- erythrocytosis, familial, 6Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- hemoglobin M diseaseInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, ClinGen, PanelApp Australia, Ambry Genetics
- unstable hemoglobin diseaseInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- beta thalassemiaInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women's Health
- beta-thalassemia and related diseasesInheritance: AR Classification: DEFINITIVE Submitted by: Natera
- beta-thalassemia HBB/LCRBInheritance: AR, SD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics
- sickle cell diseaseInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia, Natera
- sickle cell disease and related diseasesInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Heinz body anemiaInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia
- hereditary persistence of fetal hemoglobinInheritance: AD Classification: STRONG Submitted by: PanelApp Australia
- delta-beta-thalassemiaInheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia
- hereditary persistence of fetal hemoglobin-beta-thalassemia syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- beta-thalassemia intermediaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- beta-thalassemia majorInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hemoglobin C diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hemoglobin C-beta-thalassemia syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hemoglobin E diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hemoglobin E-beta-thalassemia syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary persistence of fetal hemoglobin-sickle cell disease syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- sickle cell-beta-thalassemia disease syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- sickle cell-hemoglobin c disease syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- sickle cell-hemoglobin d disease syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- sickle cell-hemoglobin E disease syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 4 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O3Absent or very rare in population | Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2]) | ||
| O7Mutational hotspot or critical domain | Moderate: ≥10 same AA change, or strong functional domain signal; No cancerhotspots.org hit at this position; UniProt domain: 131 pathogenic, 51 benign (OR vs. background: 12.8).; ±8 AA neighbourhood: 11 pathogenic, 3 benign (OR vs. background: 16.4); Variant does not impact splicing — splice-hotspot path not applicable |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000518.5. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
HBB | TSL:1MANE Select | c.433A>G p.Lys145Glu | missense | Exon 3 of 3 | Prot: ENSP00000333994.3 UniProt: | |
HBB | c.433A>G p.Lys145Glu | missense | Exon 3 of 3 | Prot: ENSP00000494175.1 UniProt: | ||
HBB | c.433A>G p.Lys145Glu | missense | Exon 4 of 4 | Prot: ENSP00000553592.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 3 sources | |||||
GnomAD3 genomes | Cov:33 | ||||
GnomAD4 exome | Cov:31 | ||||
GnomAD4 genome | Cov:33 | ||||
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 25 | |
AlphaMissense | Pathogenic | 0.76 | |
BayesDel_addAF | Pathogenic | 0.25 | D |
BayesDel_noAF | Uncertain | 0.11 | |
CADD | Benign | 22 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Benign | 0.038 | T |
Eigen | Benign | -0.13 | |
Eigen_PC | Benign | -0.062 | |
FATHMM_MKL | Uncertain | 0.82 | D |
FuncVEP CTI | Benign | 0.11 | |
GPN-Star LLR | N/A | -6.7 | |
GPN-Star score | N/A | 6.7 | |
LIST_S2 | Uncertain | 0.86 | D |
M_CAP | Pathogenic | 0.47 | D |
MetaRNN | Benign | 0.39 | T |
MetaSVM | Uncertain | 0.33 | D |
Mutation Taster | N/A | 5/95 | disease causing |
MutationAssessor | Pathogenic | 3.0 | M |
PhyloP100 | Benign | 1.2 | |
popEVE | Benign | -3.2 | |
PrimateAI | Benign | 0.40 | T |
PROVEAN | Benign | -1.9 | N |
REVEL | Uncertain | 0.57 | |
Sift | Uncertain | 0.0080 | D |
Sift4G | Benign | 0.12 | T |
Varity_R | N/A | 0.49 | |
VESM-3B | Benign | -8.9 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.030 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.